Loading clinical trials...
Loading clinical trials...
A Double-blind, Randomized, Parallel-group, Vehicle-controlled, Multi-center Study to Evaluate the Safety and Clinical Equivalence of a Generic Ciclopirox Olamine Topical Suspension to Reference Ciclopirox Topical Suspension 0.77% in the Treatment of Tinea Pedis
Conditions
Interventions
Ciclopirox Olamine Topical Suspension
Ciclopirox Topical Suspension 0.77%-Reference Product
+1 more
Start Date
June 1, 2004
Primary Completion Date
December 1, 2004
Completion Date
April 1, 2005
Last Updated
October 27, 2021
NCT07245667
NCT00233493
NCT03129321
NCT03897257
NCT02842021
NCT04203342
Lead Sponsor
Padagis LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions